Adrestia Therapeutics
About:
Adrestia is developing therapeutics that work in an entirely new way – restoring the biological balance in damaged, diseased or dying cells
Website: https://www.adrestia.com
Twitter/X: AdrestiaTherap
Top Investors: Ahren Innovation Capital, GlaxoSmithKline
Description:
Adrestia Therapeutics are leaders in synthetic rescue, an approach that decodes the complexity of genetic networks to reveal new ways to treat diseases.
Total Funding Amount:
172M GBP
Headquarters Location:
Babraham, Cambridgeshire, United Kingdom
Founded Date:
2017-01-01
Contact Email:
info(AT)adrestia.com
Founders:
Gabriel Balmus, Rafael E. Carazo, Stephen Jackson, Yaron Galanty
Number of Employees:
11-50
Last Funding Date:
2020-12-18
IPO Status:
Private
Industries:
© 2025 bioDAO.ai